Related Experiment Video

Updated: Sep 27, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Charlson Comorbidity Index in Predicting Poor Clinical Outcomes and Mortality in Patients with COVID-19

Serap Argun Barış1, Haşim Boyacı1, Sıla Akhan2

  • 1Department of Pulmonary Diseases, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.

Turkish Thoracic Journal
|April 11, 2022
PubMed

Insights

The Charlson Comorbidity Index effectively predicts poor outcomes and mortality in coronavirus disease 19 (COVID-19) patients. This index aids in identifying high-risk individuals for better clinical management.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Geriatrics

Background:

  • Older age and comorbidities are known risk factors for poor outcomes in COVID-19.
  • Predictive tools are crucial for managing COVID-19 patients effectively.

Purpose of the Study:

  • To evaluate the Charlson Comorbidity Index (CCI) for predicting poor clinical outcomes in COVID-19 patients.
  • To assess the association between CCI and adverse events such as pneumonia, respiratory failure, ICU admission, and mortality.

Main Methods:

  • Retrospective analysis of demographic data and clinical outcomes in COVID-19 patients.
  • Calculation of classical and modified Charlson Comorbidity Index, age-adjusted.
  • Evaluation of outcomes including pneumonia, respiratory failure, ICU admission, and mortality.

Main Results:

  • Comorbidity rate was 50.7%, with hypertension and diabetes being most common.
  • Pneumonia, respiratory failure, and ICU admission were significantly higher in patients with comorbidities.
  • Higher CCI scores (classical, modified, and age-adjusted) were associated with poor clinical outcomes and mortality.

Conclusions:

  • The Charlson Comorbidity Index is a valuable tool for predicting poor clinical outcomes in COVID-19.
  • CCI evaluation can aid in risk stratification and management of COVID-19 patients.
  • Early identification of high-risk patients through CCI can improve patient outcomes and resource allocation.
Abstract

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

254
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
486
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
648
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34